sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global Pandemic Influenza Vaccine Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Pandemic Influenza Vaccine Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Category : Pharmaceuticals and Healthcare QY Research Pages :113
Published Date : 2020-12-15

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the Pandemic Influenza Vaccine Market with our analysts monitoring the situation across the globe.
Pandemic Influenza Vaccine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pandemic Influenza Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026. Segment by Type, the Pandemic Influenza Vaccine market is segmented into Influenza A (H1N1) Vaccines Other Segment by Application, the Pandemic Influenza Vaccine market is segmented into Adult Paediatric Regional and Country-level Analysis The Pandemic Influenza Vaccine market is analysed and market size information is provided by regions (countries). The key regions covered in the Pandemic Influenza Vaccine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026. Competitive Landscape and Pandemic Influenza Vaccine Market Share Analysis Pandemic Influenza Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pandemic Influenza Vaccine business, the date to enter into the Pandemic Influenza Vaccine market, Pandemic Influenza Vaccine product introduction, recent developments, etc. The major vendors covered: AstraZeneca GlaxoSmithKline Novartis Sanofi Valneva Lupin Chiron Panacea Solvay and Serum Institute of India Pvt. Ltd. Sementis
1 Study Coverage 1.1 Pandemic Influenza Vaccine Product Introduction 1.2 Market Segments 1.3 Key Pandemic Influenza Vaccine Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type 1.4.2 Influenza A (H1N1) Vaccines 1.4.3 Other 1.5 Market by Application 1.5.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application 1.5.2 Adult 1.5.3 Paediatric 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Pandemic Influenza Vaccine Market Size, Estimates and Forecasts 2.1.1 Global Pandemic Influenza Vaccine Revenue 2015-2026 2.1.2 Global Pandemic Influenza Vaccine Sales 2015-2026 2.2 Global Pandemic Influenza Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026 2.2.1 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Pandemic Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Pandemic Influenza Vaccine Competitor Landscape by Players 3.1 Pandemic Influenza Vaccine Sales by Manufacturers 3.1.1 Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020) 3.1.2 Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2015-2020) 3.2 Pandemic Influenza Vaccine Revenue by Manufacturers 3.2.1 Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020) 3.2.2 Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2019 3.2.5 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Pandemic Influenza Vaccine Price by Manufacturers 3.4 Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Types 3.4.1 Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Pandemic Influenza Vaccine Product Type 3.4.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global Pandemic Influenza Vaccine Market Size by Type (2015-2020) 4.1.1 Global Pandemic Influenza Vaccine Sales by Type (2015-2020) 4.1.2 Global Pandemic Influenza Vaccine Revenue by Type (2015-2020) 4.1.3 Pandemic Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Pandemic Influenza Vaccine Market Size Forecast by Type (2021-2026) 4.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Type (2021-2026) 4.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Type (2021-2026) 4.2.3 Pandemic Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Pandemic Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Market Size by Application (2015-2026) 5.1 Global Pandemic Influenza Vaccine Market Size by Application (2015-2020) 5.1.1 Global Pandemic Influenza Vaccine Sales by Application (2015-2020) 5.1.2 Global Pandemic Influenza Vaccine Revenue by Application (2015-2020) 5.1.3 Pandemic Influenza Vaccine Price by Application (2015-2020) 5.2 Pandemic Influenza Vaccine Market Size Forecast by Application (2021-2026) 5.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Application (2021-2026) 5.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Application (2021-2026) 5.2.3 Global Pandemic Influenza Vaccine Price Forecast by Application (2021-2026) 6 North America 6.1 North America Pandemic Influenza Vaccine by Country 6.1.1 North America Pandemic Influenza Vaccine Sales by Country 6.1.2 North America Pandemic Influenza Vaccine Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Pandemic Influenza Vaccine Market Facts & Figures by Type 6.3 North America Pandemic Influenza Vaccine Market Facts & Figures by Application 7 Europe 7.1 Europe Pandemic Influenza Vaccine by Country 7.1.1 Europe Pandemic Influenza Vaccine Sales by Country 7.1.2 Europe Pandemic Influenza Vaccine Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Pandemic Influenza Vaccine Market Facts & Figures by Type 7.3 Europe Pandemic Influenza Vaccine Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Pandemic Influenza Vaccine by Region 8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Region 8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Type 8.3 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Application 9 Latin America 9.1 Latin America Pandemic Influenza Vaccine by Country 9.1.1 Latin America Pandemic Influenza Vaccine Sales by Country 9.1.2 Latin America Pandemic Influenza Vaccine Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Pandemic Influenza Vaccine Market Facts & Figures by Type 9.3 Central & South America Pandemic Influenza Vaccine Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Pandemic Influenza Vaccine by Country 10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Country 10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Type 10.3 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Application 11 Company Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Corporation Information 11.1.2 AstraZeneca Description and Business Overview 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020) 11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered 11.1.5 AstraZeneca Related Developments 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Corporation Information 11.2.2 GlaxoSmithKline Description and Business Overview 11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 11.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered 11.2.5 GlaxoSmithKline Related Developments 11.3 Novartis 11.3.1 Novartis Corporation Information 11.3.2 Novartis Description and Business Overview 11.3.3 Novartis Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Novartis Pandemic Influenza Vaccine Products Offered 11.3.5 Novartis Related Developments 11.4 Sanofi 11.4.1 Sanofi Corporation Information 11.4.2 Sanofi Description and Business Overview 11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Sanofi Pandemic Influenza Vaccine Products Offered 11.4.5 Sanofi Related Developments 11.5 Valneva 11.5.1 Valneva Corporation Information 11.5.2 Valneva Description and Business Overview 11.5.3 Valneva Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Valneva Pandemic Influenza Vaccine Products Offered 11.5.5 Valneva Related Developments 11.6 Lupin 11.6.1 Lupin Corporation Information 11.6.2 Lupin Description and Business Overview 11.6.3 Lupin Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Lupin Pandemic Influenza Vaccine Products Offered 11.6.5 Lupin Related Developments 11.7 Chiron Panacea 11.7.1 Chiron Panacea Corporation Information 11.7.2 Chiron Panacea Description and Business Overview 11.7.3 Chiron Panacea Sales, Revenue and Gross Margin (2015-2020) 11.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered 11.7.5 Chiron Panacea Related Developments 11.8 Solvay and Serum Institute of India Pvt. Ltd. 11.8.1 Solvay and Serum Institute of India Pvt. Ltd. Corporation Information 11.8.2 Solvay and Serum Institute of India Pvt. Ltd. Description and Business Overview 11.8.3 Solvay and Serum Institute of India Pvt. Ltd. Sales, Revenue and Gross Margin (2015-2020) 11.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered 11.8.5 Solvay and Serum Institute of India Pvt. Ltd. Related Developments 11.9 Sementis 11.9.1 Sementis Corporation Information 11.9.2 Sementis Description and Business Overview 11.9.3 Sementis Sales, Revenue and Gross Margin (2015-2020) 11.9.4 Sementis Pandemic Influenza Vaccine Products Offered 11.9.5 Sementis Related Developments 11.1 AstraZeneca 11.1.1 AstraZeneca Corporation Information 11.1.2 AstraZeneca Description and Business Overview 11.1.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020) 11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered 11.1.5 AstraZeneca Related Developments 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Pandemic Influenza Vaccine Market Estimates and Projections by Region 12.1.1 Global Pandemic Influenza Vaccine Sales Forecast by Regions 2021-2026 12.1.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2021-2026 12.2 North America Pandemic Influenza Vaccine Market Size Forecast (2021-2026) 12.2.1 North America: Pandemic Influenza Vaccine Sales Forecast (2021-2026) 12.2.2 North America: Pandemic Influenza Vaccine Revenue Forecast (2021-2026) 12.2.3 North America: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026) 12.3 Europe Pandemic Influenza Vaccine Market Size Forecast (2021-2026) 12.3.1 Europe: Pandemic Influenza Vaccine Sales Forecast (2021-2026) 12.3.2 Europe: Pandemic Influenza Vaccine Revenue Forecast (2021-2026) 12.3.3 Europe: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Pandemic Influenza Vaccine Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Pandemic Influenza Vaccine Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Pandemic Influenza Vaccine Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Pandemic Influenza Vaccine Market Size Forecast by Region (2021-2026) 12.5 Latin America Pandemic Influenza Vaccine Market Size Forecast (2021-2026) 12.5.1 Latin America: Pandemic Influenza Vaccine Sales Forecast (2021-2026) 12.5.2 Latin America: Pandemic Influenza Vaccine Revenue Forecast (2021-2026) 12.5.3 Latin America: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Pandemic Influenza Vaccine Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Pandemic Influenza Vaccine Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Pandemic Influenza Vaccine Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Pandemic Influenza Vaccine Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter's Five Forces Analysis 13.5 Primary Interviews with Key Pandemic Influenza Vaccine Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Pandemic Influenza Vaccine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

Get Free Sample

List of Tables Table 1. Pandemic Influenza Vaccine Market Segments Table 2. Ranking of Global Top Pandemic Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Pandemic Influenza Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million) Table 4. Major Manufacturers of Influenza A (H1N1) Vaccines Table 5. Major Manufacturers of Other Table 6. Global Pandemic Influenza Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses) Table 7. Global Pandemic Influenza Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026 Table 8. Global Pandemic Influenza Vaccine Sales by Regions 2015-2020 (K Doses) Table 9. Global Pandemic Influenza Vaccine Sales Market Share by Regions (2015-2020) Table 10. Global Pandemic Influenza Vaccine Revenue by Regions 2015-2020 (US$ Million) Table 11. Global Pandemic Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses) Table 12. Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2015-2020) Table 13. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 14. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pandemic Influenza Vaccine as of 2019) Table 15. Pandemic Influenza Vaccine Revenue by Manufacturers (2015-2020) (US$ Million) Table 16. Pandemic Influenza Vaccine Revenue Share by Manufacturers (2015-2020) Table 17. Key Manufacturers Pandemic Influenza Vaccine Price (2015-2020) (USD/Dose) Table 18. Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters Table 19. Manufacturers Pandemic Influenza Vaccine Product Type Table 20. Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Global Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses) Table 23. Global Pandemic Influenza Vaccine Sales Share by Type (2015-2020) Table 24. Global Pandemic Influenza Vaccine Revenue by Type (2015-2020) (US$ Million) Table 25. Global Pandemic Influenza Vaccine Revenue Share by Type (2015-2020) Table 26. Pandemic Influenza Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose) Table 27. Global Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses) Table 28. Global Pandemic Influenza Vaccine Sales Share by Application (2015-2020) Table 29. North America Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses) Table 30. North America Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020) Table 31. North America Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million) Table 32. North America Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020) Table 33. North America Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses) Table 34. North America Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020) Table 35. North America Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses) Table 36. North America Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020) Table 37. Europe Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses) Table 38. Europe Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020) Table 39. Europe Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million) Table 40. Europe Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020) Table 41. Europe Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses) Table 42. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020) Table 43. Europe Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses) Table 44. Europe Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020) Table 45. Asia Pacific Pandemic Influenza Vaccine Sales by Region (2015-2020) (K Doses) Table 46. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020) Table 47. Asia Pacific Pandemic Influenza Vaccine Revenue by Region (2015-2020) (US$ Million) Table 48. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020) Table 49. Asia Pacific Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses) Table 50. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020) Table 51. Asia Pacific Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses) Table 52. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020) Table 53. Latin America Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses) Table 54. Latin America Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020) Table 55. Latin Americaa Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million) Table 56. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020) Table 57. Latin America Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses) Table 58. Latin America Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020) Table 59. Latin America Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses) Table 60. Latin America Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020) Table 61. Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2015-2020) (K Doses) Table 62. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country (2015-2020) Table 63. Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2015-2020) (US$ Million) Table 64. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country (2015-2020) Table 65. Middle East and Africa Pandemic Influenza Vaccine Sales by Type (2015-2020) (K Doses) Table 66. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020) Table 67. Middle East and Africa Pandemic Influenza Vaccine Sales by Application (2015-2020) (K Doses) Table 68. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020) Table 69. AstraZeneca Corporation Information Table 70. AstraZeneca Description and Major Businesses Table 71. AstraZeneca Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 72. AstraZeneca Product Table 73. AstraZeneca Recent Development Table 74. GlaxoSmithKline Corporation Information Table 75. GlaxoSmithKline Description and Major Businesses Table 76. GlaxoSmithKline Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 77. GlaxoSmithKline Product Table 78. GlaxoSmithKline Recent Development Table 79. Novartis Corporation Information Table 80. Novartis Description and Major Businesses Table 81. Novartis Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 82. Novartis Product Table 83. Novartis Recent Development Table 84. Sanofi Corporation Information Table 85. Sanofi Description and Major Businesses Table 86. Sanofi Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 87. Sanofi Product Table 88. Sanofi Recent Development Table 89. Valneva Corporation Information Table 90. Valneva Description and Major Businesses Table 91. Valneva Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 92. Valneva Product Table 93. Valneva Recent Development Table 94. Lupin Corporation Information Table 95. Lupin Description and Major Businesses Table 96. Lupin Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 97. Lupin Product Table 98. Lupin Recent Development Table 99. Chiron Panacea Corporation Information Table 100. Chiron Panacea Description and Major Businesses Table 101. Chiron Panacea Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 102. Chiron Panacea Product Table 103. Chiron Panacea Recent Development Table 104. Solvay and Serum Institute of India Pvt. Ltd. Corporation Information Table 105. Solvay and Serum Institute of India Pvt. Ltd. Description and Major Businesses Table 106. Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 107. Solvay and Serum Institute of India Pvt. Ltd. Product Table 108. Solvay and Serum Institute of India Pvt. Ltd. Recent Development Table 109. Sementis Corporation Information Table 110. Sementis Description and Major Businesses Table 111. Sementis Pandemic Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 112. Sementis Product Table 113. Sementis Recent Development Table 114. Global Pandemic Influenza Vaccine Sales Forecast by Regions (2021-2026) (K Doses) Table 115. Global Pandemic Influenza Vaccine Sales Market Share Forecast by Regions (2021-2026) Table 116. Global Pandemic Influenza Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million) Table 117. Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Regions (2021-2026) Table 118. North America: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses) Table 119. North America: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 120. Europe: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses) Table 121. Europe: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 122. Asia Pacific: Pandemic Influenza Vaccine Sales Forecast by Region (2021-2026) (K Doses) Table 123. Asia Pacific: Pandemic Influenza Vaccine Revenue Forecast by Region (2021-2026) (US$ Million) Table 124. Latin America: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses) Table 125. Latin America: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 126. Middle East and Africa: Pandemic Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses) Table 127. Middle East and Africa: Pandemic Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million) Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 129. Key Challenges Table 130. Market Risks Table 131. Main Points Interviewed from Key Pandemic Influenza Vaccine Players Table 132. Pandemic Influenza Vaccine Customers List Table 133. Pandemic Influenza Vaccine Distributors List Table 134. Research Programs/Design for This Report Table 135. Key Data Information from Secondary Sources Table 136. Key Data Information from Primary Sources List of Figures Figure 1. Pandemic Influenza Vaccine Product Picture Figure 2. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2020 & 2026 Figure 3. Influenza A (H1N1) Vaccines Product Picture Figure 4. Other Product Picture Figure 5. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2020 & 2026 Figure 6. Adult Figure 7. Paediatric Figure 8. Pandemic Influenza Vaccine Report Years Considered Figure 9. Global Pandemic Influenza Vaccine Market Size 2015-2026 (US$ Million) Figure 10. Global Pandemic Influenza Vaccine Sales 2015-2026 (K Doses) Figure 11. Global Pandemic Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Global Pandemic Influenza Vaccine Sales Market Share by Region (2015-2020) Figure 13. Global Pandemic Influenza Vaccine Sales Market Share by Region in 2019 Figure 14. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2015-2020) Figure 15. Global Pandemic Influenza Vaccine Revenue Market Share by Region in 2019 Figure 16. Global Pandemic Influenza Vaccine Sales Share by Manufacturer in 2019 Figure 17. The Top 10 and 5 Players Market Share by Pandemic Influenza Vaccine Revenue in 2019 Figure 18. Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Pandemic Influenza Vaccine Sales Market Share by Type (2015-2020) Figure 20. Global Pandemic Influenza Vaccine Sales Market Share by Type in 2019 Figure 21. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2015-2020) Figure 22. Global Pandemic Influenza Vaccine Revenue Market Share by Type in 2019 Figure 23. Global Pandemic Influenza Vaccine Market Share by Price Range (2015-2020) Figure 24. Global Pandemic Influenza Vaccine Sales Market Share by Application (2015-2020) Figure 25. Global Pandemic Influenza Vaccine Sales Market Share by Application in 2019 Figure 26. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2015-2020) Figure 27. Global Pandemic Influenza Vaccine Revenue Market Share by Application in 2019 Figure 28. North America Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses) Figure 29. North America Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 30. North America Pandemic Influenza Vaccine Sales Market Share by Country in 2019 Figure 31. North America Pandemic Influenza Vaccine Revenue Market Share by Country in 2019 Figure 32. U.S. Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 33. U.S. Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Canada Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 35. Canada Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. North America Pandemic Influenza Vaccine Market Share by Type in 2019 Figure 37. North America Pandemic Influenza Vaccine Market Share by Application in 2019 Figure 38. Europe Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses) Figure 39. Europe Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 40. Europe Pandemic Influenza Vaccine Sales Market Share by Country in 2019 Figure 41. Europe Pandemic Influenza Vaccine Revenue Market Share by Country in 2019 Figure 42. Germany Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 43. Germany Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. France Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 45. France Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. U.K. Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 47. U.K. Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Italy Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 49. Italy Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Russia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 51. Russia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Europe Pandemic Influenza Vaccine Market Share by Type in 2019 Figure 53. Europe Pandemic Influenza Vaccine Market Share by Application in 2019 Figure 54. Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses) Figure 55. Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 56. Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Region in 2019 Figure 57. Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Region in 2019 Figure 58. China Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 59. China Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Japan Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 61. Japan Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. South Korea Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 63. South Korea Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. India Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 65. India Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Australia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 67. Australia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Taiwan Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 69. Taiwan Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Indonesia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 71. Indonesia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Thailand Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 73. Thailand Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Malaysia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 75. Malaysia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Philippines Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 77. Philippines Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Vietnam Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 79. Vietnam Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Asia Pacific Pandemic Influenza Vaccine Market Share by Type in 2019 Figure 81. Asia Pacific Pandemic Influenza Vaccine Market Share by Application in 2019 Figure 82. Latin America Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses) Figure 83. Latin America Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 84. Latin America Pandemic Influenza Vaccine Sales Market Share by Country in 2019 Figure 85. Latin America Pandemic Influenza Vaccine Revenue Market Share by Country in 2019 Figure 86. Mexico Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 87. Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 88. Brazil Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 89. Brazil Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 90. Argentina Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 91. Argentina Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Latin America Pandemic Influenza Vaccine Market Share by Type in 2019 Figure 93. Latin America Pandemic Influenza Vaccine Market Share by Application in 2019 Figure 94. Middle East and Africa Pandemic Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses) Figure 95. Middle East and Africa Pandemic Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million) Figure 96. Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Country in 2019 Figure 97. Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Country in 2019 Figure 98. Turkey Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 99. Turkey Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 100. Saudi Arabia Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 101. Saudi Arabia Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 102. U.A.E Pandemic Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses) Figure 103. U.A.E Pandemic Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. Middle East and Africa Pandemic Influenza Vaccine Market Share by Type in 2019 Figure 105. Middle East and Africa Pandemic Influenza Vaccine Market Share by Application in 2019 Figure 106. North America Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses) Figure 107. North America Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 108. Europe Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses) Figure 109. Europe Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 110. Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses) Figure 111. Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 112. Latin America Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses) Figure 113. Latin America Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 114. Middle East and Africa Pandemic Influenza Vaccine Sales Growth Rate Forecast (2021-2026) (K Doses) Figure 115. Middle East and Africa Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 116. Porter's Five Forces Analysis Figure 117. Channels of Distribution Figure 118. Distributors Profiles Figure 119. Bottom-up and Top-down Approaches for This Report Figure 120. Data Triangulation Figure 121. Key Executives Interviewed

Get Free Sample

Related Reports

Global Pandemic Influenza Vaccine Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global Pandemic Influenza Vaccine Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global Pandemic Influenza Vaccine Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global Pandemic Influenza Vaccine Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global Pandemic Influenza Vaccine Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2020-2027

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)